Summary
We have studied the metabolism of doxorubicin in rat and mouse liver, heart and hepatocytes. Doxorubicinol was present in all cases at very low levels and 7-deoxyaglycones were present only in extraphysiological conditions: no aglycones were found either in fresh livers or in hearts of animals treated with the drug, but they were produced in large amounts when the organs were left at room temperature after the death of the animal. Hepatocytes grown in primary cultures or hepatoma cells grown in continuous lines produced no 7-deoxyaglycones. Freshly isolated hepatocytes synthesized small amounts of 7-deoxyaglycones; however, when these hepatocytes were homogenized prior to incubation, high levels of 7-deoxyaglycones were produced. We conclude that 7-deoxyaglycone formation is possible only in injured tissue and is not, therefore, a normal pathway for doxorubicin.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Benjamin R.S., Riggs CE. and Bachur N.R. (1973): Pharmacokinetics and metabolism of adriamycin in man. Clin. Pharmacol. Ther., 14, 592–600.
Takanashi S. and Bachur N.R. (1976): Adriamycin metabolism in man. Evidence from urinary metabolites. Drug Metab. Dispos., 4, 79–87.
Benjamin R.S., Riggs C.E. and Bachur N.R. (1977): Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res., 37, 1416–1420.
Wilkinson P.M., Israel M., Pegg W.J. and Frei E. (1979): Comparative metabolism and excretion of adriamycin in man, monkey and rat. Cancer Chemother Pharmacol., 2, 121–125.
Israel M., Wilkinson P.M., Pegg W.J. and Frei E. (1978): Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyl adriamycin-14-valerate in the rat. Cancer Res., 38, 365–370.
Robert J., Iliadis A., Hoerni B., Cano J.P. and Lagarde C. (1982): Pharmacokinetics of adriamycin in patients with breast cancer: correlation between pharmacokinetic parameters and clinical short-term response. Eur. J. Cancer Clin. Oncol., 18, 739–745.
Bachur N.R. and Gee M. (1976): Microsomal reductive glycosidase. J. Pharmacol. Exp. Ther., 197, 681–686.
Loveless H., Arena E., Felsted R.L. and Bachur N.R. (1978): Comparative mammalian metabolism of adriamycin and daunorubicin. Cancer Res., 38, 593–598.
Berry M.N. and Friend D.S. (1969): High yield preparation of isolated rat liver parenchymal cells. J. Cell Biol., 43, 506–520.
Klaunig J.E., Goldblatt P.J., Hinton D.E., Lipsky M.M. Chako J. and Trump B.F. (1981): Mouse liver cell culture. I. Hepatocyte isolation. In Vitro, 17, 913–925.
Klaunig J.E., Goldblatt P.J., Hinton D.E., Lipsky M.M. and Trump B.P. (1981): Mouse liver cell culture. II. Primary culture. In Vitro, 17, 926–934.
Thompson E.B., Tomkins G.M. and Curran J.S. (1966): Induction of tyrosine-ketoglutarate transaminase by steroid hormones. Proc. Natl. Acad. Sei. USA, 58, 296–303.
Baurain R., Zenebergh A., Trouet A. (1978): Cellular uptake and metabolism of daunorubicin as determined by high pressure liquid chromatography: application to L1210 cells. J. Chromatogr., 157, 331–336.
Israel M., Pegg W.J., Wilkinson P.M. and Garnick M.B. (1978): Liquid chromatographic analysis of adriamycin and metabolites in biological fluids. J. Liquid Chromatogr., 1, 795–809.
Israel M., Pegg W.J., Wilkinson P.M. and Garnick M.B. (1978): HPLC applications in the analysis of adriamycin and analysis in biological fluids.In: Biological biomedical applications of liquid chromatography. Hawk J.L., ed. New York: Marcel Dekker, 413–428.
Tavoloni N. and Guarino A.M. (1980): Disposition and metabolism of adriamycin in the rat. Pharmacology, 21, 244–255.
Riggs C.E., Benjamin R.S., Serpick A.A. and Bachur N.R. (1977): Biliary disposition of adriamycin. Clin. Pharmacol Ther., 22, 234–241.
Ehninger G., Stocker H.J., Proksch B. and Wilms K. (1980): Die Pharmakokinetik von Adriamycin und Adriamycin-Metaboliten. Klin. Wochenschr., 58, 927–934.
Piazza E., Donelli M.G., Broggoni M., Jessa C, Natale N., Ottolenghi L., Marsoni S., Libretti A., Manzioni C. and Morasca L. (1980): Early-phase pharmacokinetics of doxorubicin in plasma of cancer patients during single or multiple drug therapy. Cancer Treat. Rep., 64, 845–854.
Gil P., Favre R., Durand A., Iliadis A., Cano J.P. and Carcassonne Y. (1983): Time dependency of adriamycin and adriamycinol kinetics. Cancer Chemother Pharmacol., 10, 120–124.
Robert J., Vrignaud P., Iliadis A., Eghbali H. and Hoerni B. (1983): Etude pharmacocinétique de la doxorubicine dans le traitement des lymphomes malins non-Hodgkiniens. Nouv. Rev. Fr. Hématol., 25, 91–95.
Egorin M.J., Clawson R.E., Ross L.A., Chou F.T.E., Andrews P.A. and Bachur N.R. (1981): Disposition and metabolism of adriamycin octanoylhydrazone in mice and rabbits. Drug Metab. Dispos., 9, 240–245.
Bolanowska N. and Gessner T. (1982): Body residue and metabolism of adriamycin and daunorubicin in control and phenobarbital-pretreated mice. Xenobiotica, 12, 125–136.
Arcamone F., Lazzati M., Vicario G.P. and Zini G. (1984): Disposition of14C-labelled 4′-epidoxorubicin and doxorubicin in the rat. A comparative study. Cancer Chemother Pharmacol., 12, 157–166.
Noel G., Peterson C, Trouet A. and Tulkens P. (1978): Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts. Eur. J. Cancer, 14, 363–368.
Zenebergh A., Baurain R. and Trouet A. (1982): Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells. Comparison with daunorubicin and doxorubicin. Cancer Chemother Pharmacol., 8, 243–249.
Egorin M.J., Clawson R.C., Ross L.A. and Bachur N.R. (1980): Cellular Pharmacology of N,N-dimethyldaunorubicin and N,N-dimethyladriamycin. Cancer Res., 40, 1928–1933.
Nguyen-Ngoc T., Vrignaud P. and Robert J. (1984): Cellular pharmacokinetics of doxorubicin in cultured mouse sarcoma cells originating from autochthonous tumors. Oncology, 41, 55–60.
Vrignaud P., Londos-Gagliardi D. and Robert J. (1986): Cellular pharmacology of doxorubicin in sensitive and resistant rat glioblastoma cells in culture. Oncology, 43, 60–66.
Hartman N., Basseches P.J. and Powis G. (1982): Effect of cyclophosphamide pretreatment on the short-term disposition and biliary excretion of adriamycin metabolites in rat. Cancer Chemother Pharmacol., 10, 11–15.
Gewirtz G.A. (1984): Metabolism anthracycline antibiotics in rat hepatocytes. Proc. Am. Ass. Cancer Res., 25, 293.
Kennedy K.A., Siegfried J.M. Sartorelli A.C. and Tritton T.R. (1983): Effects of anthracyclines on oxygenated and hypoxic tumor cells. Cancer Res., 43, 54–59.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vrignaud, P., Londos-Gagliardi, D. & Robert, J. Hepatic metabolism of doxorubicin in mice and rats. European Journal of Drug Metabolism and Pharmacokinetics 11, 101–105 (1986). https://doi.org/10.1007/BF03189834
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189834